|
BC081116e : Breast cancer with cancer adjacent breast tissue array, including invasive carcinoma of no special type ,breast carcinoma with apocrine differentiation and AT tissue,pathology grade,IHC(ER/PR/Her-2/Ki67) info,TNM/Stage(AJCC 7th edition), 107 cases/110 cores(core size 1.5mm）, replacing BC081116d
Description
| Microarray Panel |
Breast carcinoma with cancer adjacent breast tissue microarray, containing 99 cases of invasive carcinoma of no special type (3 cases with matched cancer adjacent breast tissue), 1 breast carcinoma with apocrine differentiation, 7 cancer adjacent breat tissue, single core per block |
| Cores |
110 |
|
| Cases |
107 |
| Row number |
11 |
| Column number |
10 |
| Core Diameter (mm) |
1.5 |
| Thickness (µm) |
5 |
| Quality Control |
H&E and IHC confirmed(Her-2,ER,PR) |
| Tissue Array Type |
FFPE |
| Species |
Human |
| Applications |
Routine histology procedures including Immunohistochemistry (IHC) and In Situ Hybridization (ISH), protocols which can be found at our support page. |
| Notes |
1. TMA slides were sectioned and stored at 4°C and may not be fresh cut, but still suitable for IHC. Please request fresh cut if experiment involves phospho-specific antibodies, RNA studies, FISH or ISH, etc. A minimum of 3 slides per TMA must be purchased to cover the cost of trimming for fresh sectioning.
2. Most TMA slides were not coated with an extra layer of paraffin (tissue cores can be easily seen on the glass). To prevent tissue detachment during antigen retrieval, unbaked slides must be baked for at least 30 to 120 minutes at 60°C. before putting into xylene for de-paraffinization. Baked slides were sent out baked for 2 hours.In the following specsheet,“*” means invalid core; “-” means no applicable or negative in IHC markers. |
Mouseover and click individual cores to view high resolution images.
Specification Sheet (Sortable), tissue IDs are available in exported Excel files.
Find overlapping cases with this tissue array:
- Product Code: BC081116e
- Availability: Out Of Stock
|
Tags:
Stage (TNM),
With normal control,
With adjacent normal
- AT,
- Malignant tumor,
- Malignant tumor (stage IA),
- Malignant tumor (stage IIA),
- Malignant tumor (stage IIB),
- Malignant tumor (stage IIIA),
- Malignant tumor (stage IIIB),
- Malignant tumor (stage IIIC)